The ReadoutModerna’s imminent vaccine data, a safer take on gene therapy, & who’s going to run the FDA? By Damian Garde Nov. 12, 2020 Reprints Alex Hogan/STAT The Readout for November 12, 2020 About the Author Reprints Damian Garde National Biotech Reporter Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast. [email protected] @damiangarde
The Readout Meghana Keshavan Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
The Readout Damian Garde Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Biotech Adam Feuerstein STAT Plus: Novocure’s electric fields device prolongs survival in lung cancer, but doubts remain
Exclusive Brittany Trang STAT Plus: Hospitals want to buy doctors’ happiness with Nuance’s AI scribe. What they’re paying varies